Schering-Plough Lotrisone
Executive Summary
FDA Dermatologic & Ophthalmic Drugs Advisory Committee will meet June 29 to discuss NDA 20-010 for Lotrisone lotion (clotrimazole/betamethasone) for the treatment of tinea pedis, tinea cruris and tinea corporis